Search results: Sage Journals

Restricted accessResearch articleFirst published July, 2020

Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1,irRC,and iRECIST criteria: comparison with subjective assessment

Ying-Chieh Lai, Wen-Cheng Chang, Chun-Bing Chen [...]

Acta Radiologica

Open accessResearch articleFirst published March, 2021

Feasibility of quantitative and volumetric enhancement measurement to assess tumor response in patients with breast cancer after early neoadjuvant chemotherapy

Jie Ding, Hongyan Xiao, Weiwei Deng [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2023

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

Li-Na He, Tao Chen, Sha Fu [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published February, 2026

iRECIST: A Case Based Users Guide for Radiologists

Conor Waters, Darragh Halpenny

Canadian Association of Radiologists Journal

Restricted accessResearch articleFirst published June, 2017

Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety,Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival

Nathaniel C. Swinburne, Derek M. Biederman, Cecilia Besa [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessReview articleFirst published November, 2025

Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?

Carmine Picone, Annamaria Porto, Roberta Fusco [...]

Cancer Control

Restricted accessResearch articleFirst published July, 2019

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib

Iben R Andersen, Rene Olesen, Anders K Boysen [...]

Acta Radiologica

Restricted accessResearch articleFirst published October, 2022

Dabrafenib Versus Dabrafenib + Trametinib in BRAF -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized,Phase 2,Open-Label Multicenter Trial

Naifa L. Busaidy, Bhavana Konda, Lai Wei [...]

Thyroid®

Restricted accessReview articleFirst published March, 2018

The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST

Alessandro Inno, Giuseppe Lo Russo, Matteo Salgarello [...]

Tumori Journal

Open accessResearch articleFirst published 2022

Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC

Filippo G. Dall’Olio, Claudia Parisi, Laura Marcolin [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published July, 2020

Response evaluation for immunotherapy through semi-automatic software based on RECIST 1.1,irRC,and iRECIST criteria: comparison with subjective assessment

Ying-Chieh Lai, Wen-Cheng Chang, Chun-Bing Chen [...]

Acta Radiologica

Open accessResearch articleFirst published March, 2021

Feasibility of quantitative and volumetric enhancement measurement to assess tumor response in patients with breast cancer after early neoadjuvant chemotherapy

Jie Ding, Hongyan Xiao, Weiwei Deng [...]

Journal of International Medical Research

Open accessResearch articleFirst published 2023

Tumor response assessment by measuring the single largest lesion per organ in advanced non-small cell lung cancer patients treated with PD-1/PD-L1 inhibitor

Li-Na He, Tao Chen, Sha Fu [...]

Therapeutic Advances in Medical Oncology

Open accessReview articleFirst published February, 2026

iRECIST: A Case Based Users Guide for Radiologists

Conor Waters, Darragh Halpenny

Canadian Association of Radiologists Journal

Restricted accessResearch articleFirst published June, 2017

Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: Review of Safety,Response Evaluation Criteria in Solid Tumors 1.1 Imaging Response and Survival

Nathaniel C. Swinburne, Derek M. Biederman, Cecilia Besa [...]

Cancer Biotherapy and Radiopharmaceuticals

Open accessReview articleFirst published November, 2025

Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?

Carmine Picone, Annamaria Porto, Roberta Fusco [...]

Cancer Control

Restricted accessResearch articleFirst published July, 2019

Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib

Iben R Andersen, Rene Olesen, Anders K Boysen [...]

Acta Radiologica

Restricted accessResearch articleFirst published October, 2022

Dabrafenib Versus Dabrafenib + Trametinib in BRAF -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized,Phase 2,Open-Label Multicenter Trial

Naifa L. Busaidy, Bhavana Konda, Lai Wei [...]

Thyroid®

Restricted accessReview articleFirst published March, 2018

The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST

Alessandro Inno, Giuseppe Lo Russo, Matteo Salgarello [...]

Tumori Journal

Open accessResearch articleFirst published 2022

Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC

Filippo G. Dall’Olio, Claudia Parisi, Laura Marcolin [...]

Therapeutic Advances in Medical Oncology